| 11891426 |
CD19 variants |
Paul Rennert, Benjamin Hackel, Justin Klesmith |
2024-02-06 |
|
| 11807691 |
Compositions and methods for treatment of cancer |
Paul Rennert |
2023-11-07 |
|
| 11207339 |
Targeted cancer therapy |
Paul Rennert, John T. Schiller |
2021-12-28 |
|
| 11059904 |
Compositions and methods for tumor transduction |
Paul Rennert |
2021-07-13 |
|
| 10669349 |
Compositions and methods for treatment of cancer |
Paul Rennert |
2020-06-02 |
|
| 10662195 |
Protein kinase conjugates and inhibitors |
Juswinder Singh, Russell C. Petter, Deqiang Niu, Lixin Qiao, Arthur F. Kluge +2 more |
2020-05-26 |
|
| 10508143 |
Compositions and methods for treatment of cancer |
Paul Rennert |
2019-12-17 |
|
| 10072094 |
Compositions and methods for tumor transduction |
Paul Rennert |
2018-09-11 |
|
| 10066023 |
Compositions and methods for tumor transduction |
Paul Rennert |
2018-09-04 |
|
| 9902774 |
Method for the treatment of inflammatory disorders |
Antonin Fougerolles, Philip Gotwals, Victor Kotelianski |
2018-02-27 |
$172,864,000 |
| 9556426 |
Protein kinase conjugates and inhibitors |
Juswinder Singh, Russell C. Petter, Deqiang Niu, Lixin Qiao, Arthur F. Kluge +2 more |
2017-01-31 |
|
| 8557240 |
Method for the treatment of inflammatory disorders |
Philip Gotwals, Antonin de Fougerolles, Victor Kotelianski |
2013-10-15 |
|
| 8226950 |
Recombinant anti-VLA4 antibody molecules |
Frank J. Carr, Philip R. Tempest |
2012-07-24 |
|
| 8084031 |
Method for the treatment of inflammatory disorders |
Philip Gotwals, Antonin de Fougerolles, Victor Kotelianski |
2011-12-27 |
|
| 7829092 |
Recombinant anti-VLA4 antibody molecules |
Frank J. Carr, Philip R. Tempest |
2010-11-09 |
|
| 7482003 |
Treatment for asthma with α4-specific antibodies |
Frank J. Carr, Philip R. Tempest |
2009-01-27 |
|
| 7462353 |
Method for the treatment of inflammatory disorders |
Philip Gotwals, Antonin DeFougerolles, Victor Koteliansky |
2008-12-09 |
|
| 7176184 |
Treatment for inflammatory bowel disease with a fibronectin polypeptide |
Linda C. Burkly |
2007-02-13 |
|
| 7157086 |
Treatment for inflammatory bowel disease with α4-specific antibodies |
Frank J. Carr, Philip R. Tempest |
2007-01-02 |
|
| 6955810 |
Method for the treatment of inflammatory disorders |
Philip Gotwals, Antonin DeFougerolles, Victor Kotelianski |
2005-10-18 |
|
| 6602503 |
Recombinant anti-VLA-4 antibody molecules |
Frank J. Carr, Philip R. Tempest |
2003-08-05 |
$48,961,000 |
| 6482409 |
Treatment for inflammatory bowel disease with a vcam-1/1gG fusion protein |
Linda C. Burkly |
2002-11-19 |
$68,539,000 |
| 6307025 |
VCAM fusion proteins and DNA coding therefor |
Catherine Hession, Susan E. Goelz, Laurelee Osborn, Christopher D. Benjamin, Margaret D. Rosa |
2001-10-23 |
$48,458,000 |
| 6252043 |
Vascular cell adhesion molecule (VCAM) polypeptides |
Catherine Hession, Susan E. Goelz, Laurelee Osborn, Christopher D. Benjamin, Margaret D. Rosa |
2001-06-26 |
$99,245,000 |
| 5932214 |
Treatment for inflammatory bowel disease with VLA-4 blockers |
Linda C. Burkly |
1999-08-03 |
$134,610,000 |
